Pulse Biosciences
PLSE
45 hedge funds and large institutions have $26.1M invested in Pulse Biosciences in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 2 closing their positions.
2,800% more call options, than puts
Call options by funds: $232K | Put options by funds: $8K
900% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 2
250% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 4
224% more capital invested
Capital invested by funds: $8.06M → $26.1M (+$18.1M)
67% more funds holding
Funds holding: 27 → 45 (+18)
3.16% more ownership
Funds ownership: 6.5% → 9.66% (+3.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.45M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.38M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.06M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$656K |
| 5 |
Bank of New York Mellon
New York
|
+$327K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.78M |
| 2 |
WIM
Westside Investment Management
Santa Monica,
California
|
-$262K |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$95.2K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9.14K |
| 5 |
TCWA
Ten Capital Wealth Advisors
Spokane,
Washington
|
-$6.72K |
PLSE Hedge Fund Activity: Q2 2023 in Review
45 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2023, worth a combined $26.1M — up 224% from $8.06M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new PLSE positions and 2 closed out — a net gain of 18 holders — while 14 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock, adding an estimated $4.45M. The largest seller was Vanguard Group, cutting an estimated $1.78M.
- 45 institutional investors held Pulse Biosciences (PLSE) as of Q2 2023, up from 27 in Q1 2023.
- Funds reported $26.1M of Pulse Biosciences stock for Q2 2023, up 224% quarter-over-quarter.
- 20 funds opened new Pulse Biosciences positions in Q2 2023 and 2 closed out, a net change of +18 holders.
- The largest Pulse Biosciences buyer in Q2 2023 was BlackRock, an estimated $4.45M added.
- The largest Pulse Biosciences seller in Q2 2023 was Vanguard Group, an estimated $1.78M sold.
Based on aggregated 13F filings for Q2 2023.